With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

BioNJ CEO Debbie Hart discusses New Jersey’s life sciences growth, state investment, industry challenges and how BioNJ is ...

A global pharmaceutical company is moving into Center City next year — and it could be a “game-changing” development for Philly’s biotech scene, a leader in the space says. “We see it as a ...

Kane Biotech ( ($TSE:KNE) ) has provided an announcement. Kane Biotech has announced that its revyve Antimicrobial Wound Gel ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Pharmas have a record $1 trillion to deploy on new biotech innovation deals. All they need is for the Federal Reserve to lower rates, according to a new report from Ernst & Young. And that’s a big ...

During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion ...

The U.S. and U.K. reached a new pharmaceutical pricing agreement to boost innovation, raise U.K. payments for new medicines ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.